ENZO BIOCHEM. INC. DL-,01ENZO BIOCHEM. INC. DL-,01ENZO BIOCHEM. INC. DL-,01

ENZO BIOCHEM. INC. DL-,01

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪24.73 M‬EUR
−0.404EUR
‪−24.09 M‬EUR
‪29.47 M‬EUR
‪37.64 M‬
Beta (1Y)
1.27
Employees (FY)
136
Change (1Y)
−54 −28.42%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About Enzo Biochem, Inc.


CEO
Kara Cannon
Website
Headquarters
New York
Founded
1976
FIGI
BBG000HJ4Y64
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in August 1976 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ENZO BIOCHEM. INC. DL-,01 stocks are traded under the ticker EZB.
EZB reached its all-time high on Jan 4, 2002 with the price of 23.694 EUR, and its all-time low was 0.462 EUR and was reached on Feb 13, 2025. View more price dynamics on EZB chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track ENZO BIOCHEM. INC. DL-,01 financials in yearly and quarterly reports right on TradingView.
ENZO BIOCHEM. INC. DL-,01 is going to release the next earnings report on Mar 17, 2025. Keep track of upcoming events with our Earnings Calendar.
EZB net income for the last quarter is ‪−3.10 M‬ EUR, while the quarter before that showed ‪−12.36 M‬ EUR of net income which accounts for 74.90% change. Track more ENZO BIOCHEM. INC. DL-,01 financial stats to get the full picture.
As of Feb 28, 2025, the company has 136.00 employees. See our rating of the largest employees — is ENZO BIOCHEM. INC. DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENZO BIOCHEM. INC. DL-,01 EBITDA is ‪−6.60 M‬ EUR, and current EBITDA margin is −26.52%. See more stats in ENZO BIOCHEM. INC. DL-,01 financial statements.
Like other stocks, EZB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENZO BIOCHEM. INC. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.